The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis
Open Access
- 16 August 2014
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 1-6
Abstract
Recently, a number of studies have been performed to explore the association between CTLA-4 A49G polymorphism and rheumatoid arthritis (RA). However, the results of previous works are still controversial and ambiguous. In this work, we attempted to perform an updated meta-analysis of available case-control study in order to assess the association between CTLA-4 A49G polymorphism and RA risk. We searched the various citation databases without limits on languages. Article searching was performed by screening the references of retrieved studies manually. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated to evaluate the strength of the association. We totally compiled 27 studies in 24 articles (9805 RA patients and 10691 control subjects) into our meta-analysis work. We found significant association between CTL-A4 A49G polymorphism and RA risk (GG vs. AA: OR = 1.13, 95% CI = 1.03-1.23; GA vs. AA: OR = 1.19, 95% CI = 1.07-1.33; GA + GG vs. AA: OR = 1.18, 95% CI = 1.07-1.29). In the subgroup analysis by ethnicity, evidences of significantly increased risk was also found in both Asian (GG vs. AA: OR = 1.34, 95% CI = 1.15-1.55; GA + GG vs. AA: OR = 1.24, 95% CI = 1.08-1.41) and Caucasian population (GA vs. AA: OR = 1.19, 95% CI = 1.03-1.37; GA + GG vs. AA: OR = 1.14, 95% CI = 1.01-1.29). No evidence of publication bias was found in this work. Our meta-analysis suggests that CTLA-4 A49G polymorphism was associated with RA risk. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/13000_2014_157Keywords
This publication has 41 references indexed in Scilit:
- CTLA-4 Expression and Polymorphisms in Lung Tissue of Patients with Diagnosed Non-Small-Cell Lung CancerBioMed Research International, 2013
- Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerJournal of Translational Medicine, 2013
- CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis—results and the review of the literatureClinical Rheumatology, 2011
- Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markersAnnals of the Rheumatic Diseases, 2010
- The +49A>G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican populationClinica Chimica Acta, 2010
- Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisitedDiagnostic Pathology, 2009
- Geographic Variation in Rheumatoid Arthritis Incidence Among Women in the United StatesArchives of internal medicine (1960), 2008
- Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han populationEuropean Journal of Human Genetics, 2005
- CTLA-4 gene polymorphism in promoter and exon-1 regions is not associated with Chinese patients with rheumatoid arthritisClinical Rheumatology, 2004
- Association of CTLA4 gene A-G polymorphism with rheumatoid arthritis in ChineseClinical Rheumatology, 2003